Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature by Stubbs, D. J. et al.
Vol.:(0123456789) 
https://doi.org/10.1007/s00701-021-04879-z
ORIGINAL ARTICLE - NEUROSURGERY GENERAL
Incidence of chronic subdural haematoma: a single‑centre exploration 
of the effects of an ageing population with a review of the literature
D. J. Stubbs1 · M. E. Vivian1 · B. M. Davies2 · A. Ercole1 · R. Burnstein1 · A. J. Joannides2
Received: 8 April 2021 / Accepted: 13 May 2021 
© The Author(s) 2021
Abstract
Background Chronic subdural haematoma (cSDH) is a common neurosurgical pathology frequently occurring in older 
patients. The impact of population ageing on cSDH caseload has not been examined, despite relevance for health system 
planning.
Methods This is a single-centre study from the UK. Operated cases of cSDH (n = 446) for 2015–2018 were identified. Crude 
and directly standardised incidence rates were calculated. Medline and EMBASE were systematically searched to identify 
studies reporting on the incidence of cSDH by year, so an estimate of rate of incidence change could be determined. Local 
incidence rates were then applied to population projections for local catchment area to estimate operated cSDH numbers at 
5 yearly intervals due to shifting demographics.
Results We identified nine studies presenting incidence estimates. Crude estimates for operative cases ranged from 
1.3/100,000/year (1.4–2.2) to 5.3/100,000/year (4.3–6.6). When non-operated cases were included, incidence was higher: 
8.2/100,000/year (6.0–11.2) to 48/100,000/year (37.7–61.1). Four pairs of studies demonstrated incidence rate increases 
of 200–600% over the last 50 years, but data was deemed too heterogeneous to generate formal estimate of incidence 
change. Local crude incidence of operated cSDH was 3.50/100,000/year (3.19–3.85). Directly standardised incidence was 
1.58/100,000/year (1.26–1.90). After applying local incidence rates to population projections, case numbers were predicted 
to increase by 53% over the next 20 years.
Conclusions The incidence of cSDH is increasing. We project a 53% increase in operative caseload within our region by 
2040. These are important findings for guiding future healthcare planning.
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Introduction
Chronic subdural haematoma (cSDH) is a common neuro-
surgical condition, consisting of a collection of altered blood 
lying beneath the dural membrane. Although widely thought 
of as the result of a progression of an acute subdural bleed, 
significant numbers occur after no significant antecedent 
trauma, perhaps due to an inflammatory process occurring 
at the level of the dural border cell [9]. cSDH is widely 
considered a disease of old age [28] with significant levels 
of comorbidity and polypharmacy present amongst those 
referred for surgery [7].
The demography of the worldwide and UK population is 
changing due to a combination of falling fertility and mor-
tality rates, and by 2039, it is estimated that the number of 
individuals aged over 60 will increase from 14.9 to 21.9 mil-
lion [12]. Such a change in population structure will lead to 
rising numbers of conditions associated with older age [12]. 
In single-centre studies examining traumatic brain injury 
(TBI) in the older patient, over 37% of cases occurred in 
those over 65, of which a third were due to SDH (both acute 
and chronic) [25]. In the context of rising admissions for TBI 
in older adults (39 million emergency department visits in 
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2009–2010 in the USA) [18], the number of patients pre-
senting for cSDH surgery is likely to increase substantially.
Patients presenting with cSDH will require contact with 
neurosurgical centres for decisions regarding surgery, the 
operation itself, and immediate postoperative care. Such a 
‘hub and spoke’ transfer system has the potential to create 
a bottleneck in the care of this vulnerable patient cohort. 
A 2007 audit of neurosurgical bed pressures [8] identified 
that nearly 30% of all patient bed days were due to delays in 
either surgery, inter-hospital transfer, or radiological inves-
tigation. The vast majority (92%) of these delays occurred 
in emergency neurosurgical patients [8].
In this study, our main aim is to examine how projected 
demographic shifts may change the number of cases of 
cSDH that may present for surgery at our centre and dis-
cuss the potential impact. To inform our modelling, we first 
systematically searched the literature to identify whether an 
estimate of underlying change in incidence rate could be 
incorporated into our modelling. Following this, we pre-
sent our local incidence rate of operated cSDH and, using 
population projections from the office for national statistics 
(ONS), estimate the projected change in operative workload 
that could arise due to demographic shifts.
Methods
Setting
The study centre provides neurosurgical services to hospitals 
across the East of England, a population of approximately 
5.8million in 2011 [17]. Services are provided 24 h a day, 
365 days a year. An electronic database of referrals is main-
tained by the on-call neurosurgical service. Broadly, patients 
can be considered referred from an external hospital (to 
which they will be repatriated after completion of surgery) 
or from within the study centre (for patients for whom this 
is their local secondary care centre).
Approvals
Aggregate case numbers by age were obtained as part of an 
institutionally approved retrospective evaluation of service 
as permitted in UK practice (reference PRN7703).
Systematic literature search
To provide important context to our findings and inform 
our modelling approach we systematically identified other 
studies examining the population incidence of cSDH. Med-
line and EMBASE were searched up to the  22nd April 2020 
to identify papers publishing incidence estimates of cSDH. 
Keywords to identify cSDH were combined with phrases 
to identify epidemiological or incidence studies. Subject 
headers were used where appropriate. Full search strategy is 
shown in Supplementary material. Title and abstract screen-
ing as well as data extraction was conducted by 2 authors 
(DJS and MEV) with full-text inclusion based on a priori 
determined inclusion criteria (Supplementary Material 
Table S2). Where required, incidence values were calcu-
lated using supplied case and population data in each paper 
and confidence intervals calculated using normal approxima-
tions. All incidences are expressed as n/100,000/year.
Regional incidence of operated cSDH: case 
and population definitions
For this study, cases that underwent surgery for cSDH were 
identified in the following manner. Cases were identified 
from the neurosurgical referrals database and cross-refer-
enced against theatre activity data. This is a more robust 
methodology for case ascertainment, given international 
classification of disease (ICD) codes for subdural haema-
toma are not specific [19]. All cases between 2015 and 
2018 (for which whole year information was available) 
were included. Referrals are received from hospitals close 
to the London boundary where neighbouring neurosurgical 
centres are located. As such it is conceivable that a propor-
tion of cases may have been referred to another centre and 
thus be missing from our records. To minimise this, we only 
included cases referred from hospitals located within Cam-
bridgeshire, Suffolk, Bedfordshire, and Norfolk to allow a 
more accurate estimate. The population at risk was defined 
using the 2016 population covered by these clinical com-
missioning groups as published by the Office for National 
Statistics [ONS], UK [23].
Projection of case numbers due to an ageing 
population
Calculated regional incidence rates for operated cSDH 
were applied to population projections for the same region 
as defined by the ONS [23]. This was done for the years 
2025–2040 at 5-year intervals. Upper and lower boundaries 
of this estimate were calculated using the limits of the 95% 
confidence interval for our calculated regional rate between 
2015 and 2018.
Statistics and direct standardisation
All analysis was conducted using the statistical software R 
(v 3.5.3) [20]. Confidence intervals are Poisson exact, and all 
incidences are expressed per 100,000 individuals at risk per 
year. Where necessary, 95% confidence intervals [95% CI] 
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were calculated as normal approximations using the standard 
error of the natural logarithm of the incidence rate (I).
Direct standardisation of incidence rates was performed 
to the World Health Organization (WHO) 2000–2025 world 
standard population [27]. Details of these calculations are 
shown in the Supplementary material.
Results
Systematic literature search
Literature searching identified 1342 articles with two further 
articles identified from the references of these papers, one of 
which was included and one which was excluded (published 
in Japanese). In total, nine papers were screened for details 
of published incidence rates. Details of inclusions and exclu-
sions are shown in Fig. 1.
Eight studies presented crude incidence rates for their 
population as a whole (Table 1) [2, 4, 10, 13–15, 21, 22]. 
Incidence ranged from 1.7 in the period 1967–1973 in 
Finland [10] to 48 in 2017 in North Wales [2]. For two 
studies [14, 22], incidence rate was calculated from pre-
sented case numbers. In one of these [22], estimated total 
population was calculated as the midpoint between quoted 
values for the beginning and end of the study period. Case 
ascertainment differed between studies, with earlier stud-
ies reporting on only operated or autopsy identified cSDH 
[10]. For instance, in the Mellergard study, they point out 
that in their institution, routine CT scanning for diagno-
sis did not become widespread until 1985 [15]. Studies 
which only included operated cases all report lower inci-
dences compared to those including radiological diag-
noses (Table 1). Between the two time points studied in 
one paper (1969 and 1983), there was a 250% increase in 
reported crude incidence of cSDH [15]. This is matched by 
a repeated study within North Wales which demonstrated 
an increase in incidence in those over 65 from 8.2 to 48 
between 1999 and 2017[1] as well as studies from both 
Finland [21] and Brazil [14] where data was available over 
a 25- and 8-year period, respectively.
Fig. 1  Article inclusion in 
systematic literature search for 
incidence estimates of chronic 
subdural haematoma
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However, due to the paucity of studies, mixed methods 
of case ascertainment, and lack of direct standardisation, 
comparisons are difficult and thus no formal meta-analysis 
was performed.
Four studies reported incidence stratified by age and, in 
three cases, by gender as well. One study [6] only reported 
stratified incidence rates without a crude population estimate 
(Table 2).
The importance of change in population demographics 
was highlighted in a Finnish study which demonstrated a sig-
nificant increase in incidence amongst older males between 
1990 and 2015 [21]. Over this period, incidence in males 
aged over 90 increased from 56.6 to 231. The authors also 
report a doubling of the population aged over 80 over this 
time period [21].
Regional incidence of operated cSDH in the East 
of England
Between 2015 and 2018, there were 446 cases of ini-
tial surgery for cSDH referred from hospitals in the area 
described. This reflects 86.1% of total surgery performed 
at CUH for cSDH over the same period. Over the studied 
period, the crude incidence of operated cSDH was 3.50 
(3.19–3.85). The directly standardised incidence rate was 
1.58 (1.26–1.90). The number of cases per year increased 
from 86 in 2015 to 114 in 2018. Calculated incidence rates 
by age are shown in Table 3.
Incidence rates were then applied to the ONS projections 
for the population in these counties between 2020 and 2040 
at 5-year intervals (Table 4). Compared to the 114 referrals 
seen in 2014, these estimates would suggest a 52.6% rise 
in cases of operated cSDH by 2040. Assuming that these 
counties continued to represent 86% of all referrals for cSDH 
surgery, by that time, the actual number of operated cases 
could be 202 (163–255). This trend (extrapolated to all refer-
rals) is shown in Fig. 2.
Discussion
There are two key findings from our work. Firstly, that there 
is clear literature evidence of an underlying rise in the inci-
dence of cSDH. Secondly, even assuming local incidence 
rate remains constant, we predict that population ageing 
alone could result in a 53% (23–92) increase in operations 
for cSDH by 2040 at our centre. Such findings and the medi-
cal complexity of this operative cohort mean that neurosur-
gical services will have to adapt to deal with such a rise.
Our local, crude incidence of operated cSDH of 3.5 
is broadly compatible with other estimates derived from 
operative data (Table 1). The significance of these findings 
on neurosurgical services is clearly apparent. Patients with 
cSDH exhibit a significant degree of inpatient morbid-
ity [24] that negatively impacts on length of stay. Any 
increase in this workload will further stress a system that 
already struggles to cope with the complexities of work-
load, capacity, referral and repatriation [8]. Given the 
interlinked nature of care for these medically complex 
patients, involving multiple hospitals and health systems, 
any rise in cases will require an integrated approach to 
ensure optimal care. Our systematic search strategy ena-
bles us to present an unbiased view of local incidence 
rates within the wider literature context. Two broad, unad-
justed trends are apparent. Firstly, that incidence across 
all studies increased with age and a male preponderance 
exists, with incidence in the oldest males over threefold 
higher than in women (Table 2). The results in Table 1 
Table 1  Published crude estimates of the incidence (per 100,000/year) of chronic subdural haematoma identified through systematic literature 
search
*Indicates that incidence was calculated in those aged 65 or older only. Magalhães [14] used a hospital admission authorisation code. Unclear if 
captured non-operated hospital admissions. 95% CI 95% confidence intervals calculated for all studies (for details, see “Methods”)
Author Year Location Incidence 
(/100,000/year)
Type N 95%CI
Fogelholm [10] 1967–1973 Helsinki, Finland 1.7 Operated and autopsy 64 1.4–2.2
Mellergard [15] 1969 Lund, Sweden 2.0 Operated 28 1.4–2.9
Mellergard [15] 1983 Lund, Sweden 5.3 Operated 82 4.3–6.6
Kudo [13] 1988 Awaji Island, Japan 13.1 All 66 10.3–16.7
Asghar [4] 1997–1999 North Wales 8.2 All 40 6.0–11.2
Adhiyaman [1] * 2017 North Wales 48.0 All 66 37.7–61.1
Rust [22] 2006 Tasmania 3.5 Operated 81 2.8–4.4
Rauhala [21] 1990–1995 Pirkanmaa, Finland 8.2 All 167 7.0–9.5
Rauhala[21] 2010–2015 Pirkanmaa, Finland 17.6 All 354 15.9–19.5
Magalhães[14] 2008 Brazil 1.3 Hospital admissions 2389 1.2–1.3
Magalhães[14] 2015 Brazil 2.4 Hospital admissions 4885 2.3–2.4
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could be interpreted as suggesting an increasing inci-
dence over time. Due to the disparate geographic loca-
tions of the studies as well as differences in case ascertain-
ment, the potential for confounding of this association is 
high. As such we did not attempt meta-regression or the 
incorporation of rising incidence rate into our projections. 
Some of this trend is almost certainly driven by increased 
rates of detection due to improved diagnostic technolo-
gies [15], especially when the rates in 1967–1973 [10] 
were based solely on operated or autopsy cases. However, 
Table 2  Age and sex-stratified 
incidence (per 100,000/
year) from studies identified 
in systematic review of the 
incidence of chronic subdural 
haematoma
M male, F female, 95%CI 95% confidence interval, n number of cases. Confidence intervals calculated (see 
“Methods”) for Fogelholm and Kudo studies. No confidence intervals could be calculated for the Bartek 
study as the number of cases was not presented in the paper
Study Year Location Age range Sex Incidence N 95% CI
Fogelholm [10] 1967–1973 Helsinki, Finland 20–29 M 0.25 1 0.0–1.8
F - - -
30–39 M 1.56 4 0.6–4.2
F 0.76 2 0.2–3.0
40–49 M 4.0 8 2.0–8.0
F 1.2 3 0.4–3.7
50–59 M 9.1 15 5.5–15.1
F 0.8 2 0.2–3.2
60–69 M 8.4 10 4.5–15.6
F 1.8 4 0.7–4.8
70–79 M 15.7 7 7.5–32.9
F 4.2 5 1.8–10.1
80 + M - - -
F 7.8 3 2.5–24.2
Kudo [13] 1992 Awaji Island, Japan  < 65 All 3.4 14 2.0–5.7
65 + All 58.1 52 44.3–76.3
Bartek [6] 2005–2010 Norway/Sweden 18–49 All 0.6 -
50–66 All 7.1 -
67–79 All 27.3 -
80–89 All 59.5 -
90 + All 52.0 -








90 + M 56.6
F 0








90 + M 231.0
F 94.2
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studies where incidence was calculated at different time 
points in the same population appear to suggest a true rise 
[2, 14, 15, 21]. Although some of this could arguably be 
confounded by widespread adoption of medical imaging 
technology, this should not be a significant factor for the 
rise in case numbers seen over the last decade in Brazil 
[14] or the linearity in incidence rise over the last 20 years 
in Finland [21].
Being as published incidence figures are crude, it is 
possible that this apparent rise merely reflects the chang-
ing population demographics captured in each setting [21], 
but a distinct aetiological driver could exist. Certainly, 
other authors have highlighted the higher incidence of 
SDH in those taking anticoagulant and antiplatelet medi-
cations [11], whilst rising rates of prescription of direct 
oral anticoagulant (DOAC) drugs are temporally related to 
increased admissions for bleeding complications, includ-
ing intracerebral haemorrhage [3].
Extrapolating from a single-centre study is hindered by a 
lack of external validity, and the magnitude of our findings 
cannot be directly applied to other centres. Although the 
broad trend of population ageing is well established [12], 
there will be a certain degree of heterogeneity in how this 
affects individual centres for instance based on their loca-
tion and urban/rural split. Regardless, our methodology, lit-
erature examination, and broad trend will be of interest to 
the wider community. A study from the USA used similar 
methods to ours and estimated a growth in SDH cases of 
53.3% between 2020 and 2060 [16]. Importantly, they used 
ICD codes for case ascertainment, and as such, these figures 
include cases of acute SDH (aSDH). Given the differences 
in case definition and population structure, it is difficult to 
compare the relative increase in cSDH cases directly, but 
regardless of this, as the authors highlight, this rise in work-
load is likely to outstrip projected workforce growth [16].
The key strengths and limitations of our study both 
revolve around case definition. This is a well-recognised 
problem in the literature, as ICD codes for traumatic and 
non-traumatic subdural haematoma have poor discrimina-
tive performance when compared to a clinical review of 
diagnostic imaging [19] and cannot take the spectrum of 
disease between acute and chronic subdural haematomas 
into account. As such, ‘contamination’ of the numerator 
in incidence calculations using these methods by cases of 
acute SDH is a possibility. By focusing on operated cSDH, 
we hope to have minimised this by using a clinician-coded 
database to identify cases (by diagnosis of cSDH) which was 
then cross-referenced against theatre activity data (where 
procedure codes are once again shared with operative inter-
ventions for aSDH). As well as seeking to refine our case 
definition, we also took steps to better define our population 
at risk. This was performed by excluding cases referred from 
the periphery of our region, removing patients referred from 
centres on the boundary between adjoining neurosurgical 
centres.
The impact of case definition on reported incidence is 
also apparent in the wider literature. We excluded several 
studies that did not take steps to differentiate between aSDH 
and cSDH. These represent two extremes of a spectrum of 
disease that partly explains the difficulties in case ascertain-
ment using diagnostic codes. It is however true that aSDH 
more commonly affects younger patients, is likely to be 
associated with significant extra-cranial injuries, and man-
dates a distinct surgical approach [20]. One excluded paper 
[5] justified including acute SDH in their cases of ‘chronic’ 
SDH by explaining that many cSDH contain elements of 
acute blood (acute on chronic SDH). We chose to focus on 
purely chronic cases of cSDH for which surgical techniques 
(such as burr hole drainage) are well characterised and that 
Table 3  Incidence (per 100,000 per year) of operated cases of chronic 
subdural haematoma referred from Bedfordshire, Cambridgeshire, 
Norfolk, and Suffolk (2015–2018) n = 446 (95% CI 95% confidence 
interval, population at risk defined using Office for National statistics 
2016 population projection for these counties. Confidence intervals 
are Poisson exact)
Age group N Incidence (/100,000/
year)
95% CI
0–9 0 0.00 0.00–0.24
10–19 0 0.00 0.00–0.24
20–29 3 0.20 0.04–0.57
30–39 4 0.25 0.07–0.65
40–49 14 0.83 0.46–1.40
50–59 30 1.77 1.20–2.53
60–69 65 4.32 3.33–5.51
70–79 163 15.08 12.85–17.58
80–89 147 25.71 21.72–30.21
90 + 20 15.49 9.46–23.92
Table 4  Projected increase in number of operations for chronic sub-
dural haematoma referred from Bedfordshire, Cambridgeshire, Nor-
folk, and Suffolk arising solely due to estimated changes in popula-
tion age structure 2025–2040 (95% CI 95% confidence interval). 
Projections assume locally calculated incidence rates remain con-
stant; hence this only models changes arising due to population age 
structure in the indicated year. Population projections are based on 
Office for National Statistics population projections for named coun-
ties. Confidence intervals are based on upper and lower estimates of 
calculated incidence rates (Table 3)
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can arise by both traumatic and non-traumatic means [41]. 
This was intentional, to reduce heterogeneity in our case 
definition and provide information to facilitate the planning 
of services caring for the medically complex cohort which 
this disease classically afflicts.
What our study cannot comment on is the true population 
burden of cSDH. This is likely to be substantially higher, a 
nationwide survey of UK practice suggested that just under 
70% of cSDH referrals were ultimately accepted for sur-
gery [7]. From the perspective of a neurosurgical centre, 
this unmeasured need means that we are unable to comment 
on the potential for growth in non-operative workload (e.g. 
referrals, advice, imaging) that could occur due to shifting 
population demographics. The integrity of our findings on 
operative workload however is not affected by this and is of 
vital importance for future capacity planning.
Conclusions
There is the potential, over the next 2 decades, for a signifi-
cant rise in operations and referrals for cSDH. This cohort is 
well recognised to be older and with significant comorbid-
ity [7]. A retrospective review of emergency neurosurgical 
patients over 75 demonstrates significant rates of inpatient 
complication, institutional discharge, and length of stay 
[26]. Any projected rise in cases will necessitate either an 
increase in neurosurgical capacity (within existing centres 
or new facilities), improvements in efficiency, or both. Given 
the ‘hub and spoke’ nature of neurosurgical referral, any 
approach to catering for this rise in case numbers should 
arguably look at the entirety of the patient journey. Further 
work should focus on barriers to current patient care, refine-
ment of models for projected case numbers, and modelling 
of the impact of any rise in case numbers on other aspects 
of neurosurgical and wider hospital care.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s00701- 021- 04879-z.
Fig. 2  Projected number of operations for chronic subdural haema-
toma (cSDH) from our study region between 2025 and 2040. Calcu-
lations assume constant local incidence but changing population age 
structure based on office for national statistics population projections. 
Error bars demonstrate upper and lower bounds of estimates based on 
95% confidence intervals for locally calculated incidence rate
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